Novartis Beats Q1 Expectations, Raises 2024 Outlook on Strong Drug Sales 4/23/2024

Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win 4/23/2024

Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates 4/23/2024

ImmunityBio Wins FDA Approval for First IL-15 Superagonist for NMIBC 4/23/2024

FDA Rejects Abeona’s Epidermolysis Bullosa Cell Therapy, Asks for CMC Data 4/23/2024

Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva 4/23/2024

Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US 4/19/2024

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies 4/19/2024

Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024

Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024

Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024

Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024

Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024

Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024

Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024

How to Deal With Layoff-Related Stress 4/18/2024